Yu-Min Shen, M.D.

Yu-Min Shen, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology.

Originally from Taipei, Taiwan, Dr. Shen holds a bachelor's degree in biological sciences from Stanford University in California, where he graduated with honors. He completed his medical degree at the University of California-San Diego.

Certified by the American Board of Internal Medicine in hematology and oncology, Dr. Shen joined the UT Southwestern faculty in 2004.

Recognized as the regional expert in coagulation disorders, Dr. Shen is a nonmalignant hematologic disorders specialist whose areas of clinical expertise include bleeding and clotting disorders, hemostasis, and thrombosis.

Dr. Shen was recognized for his excellence as an educator with UT Southwestern’s 2011 Eugene P. Frenkel Outstanding Teacher of the Year Award.

Dr. Shen has delivered a number of invited lectures internationally, nationally, and regionally and published more than 20 scholarly articles, chapters, reviews, and case reports. He serves as an ad hoc reviewer for the Journal of Clinical Oncology.

Dr. Shen is a member of professional organizations that include the American Society of Hematology, the International Society on Thrombosis and Haemostasis, and the Hemophilia and Thrombosis Research Society.

Medical School

University of California at San Diego School of Medicine (1995)

Internship

UT Southwestern Medical Center (1996), Internal Medicine

Residency

UT Southwestern Medical Center (1998), Internal Medicine

Fellowship

UT Southwestern Medical Center (2004), Hematology Oncology

• Antiphospholipid antibody syndrome
• Heparin-induced thrombocytopenia
• Thrombophilia testing
• Thrombosis & Hemostasis

Featured Publications

Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission.

Reddy MS, Hofmann S, Shen YM, Nagalla S, Rambally S, Usmani A, Sarode R, Transfus. Apher. Sci. 2020 Jul 102885

The role of cardiovascular disease risk assessed by ASCVD score in primary thrombosis prophylaxis strategy among antiphospholipid antibody carriers.

Zuo Y, Udupa A, Fan J, Makris UE, Karp DR, Shen YM Lupus 2018 Aug 961203318796289

Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.

Sacharidou A, Chambliss KL, Ulrich V, Salmon JE, Shen YM, Herz J, Hui DY, Terada LS, Shaul PW, Mineo C Blood 2018 Mar

Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers.

Zuo Y, Fan J, Sarode R, Zhang S, Makris UE, Karp DR, Shen YM Clin. Appl. Thromb. Hemost. 2018 Jan 1076029618755946

Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?

Yates SG, Smith S, Tharpe W, Shen YM, Sarode R Transfus. Apher. Sci. 2016 Jun

Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.

Mineo C, Lanier L, Jung E, Sengupta S, Ulrich V, Sacharidou A, Tarango C, Osunbunmi O, Shen YM, Salmon JE, Brekken RA, Huang X, Thorpe PE, Shaul PW PLoS ONE 2016 11 7 e0158757

Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost.

Shen YM, Tsai J, Taiwo E, Gavva C, Yates SG, Patel V, Frenkel E, Sarode R PLoS ONE 2016 11 5 e0155326

Characteristics and Outcomes of Renal Transplant Recipients with Hemolytic Uremic Syndrome in the United States.

Tanriover B, Lakhia R, Shen YM, Sandikci B, Saxena R, MacConmara M, Soyombo AA, Rajora N, Hardy MA Transplant Direct 2015 Nov 1 10

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, Della Peruta M, Lheriteau E, Patel N, Raj D, Riddell A, Pie J, Rangarajan S, Bevan D, Recht M, Shen YM, Halka KG, Basner-Tschakarjan E, Mingozzi F, High KA, Allay J, Kay MA, Ng CY, Zhou J, Cancio M, Morton CL, Gray JT, Srivastava D, Nienhuis AW, Davidoff AM N. Engl. J. Med. 2014 Nov 371 21 1994-2004

Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Ulrich V, Konaniah ES, Lee WR, Khadka S, Shen YM, Herz J, Salmon JE, Hui DY, Shaul PW, Mineo C J Am Heart Assoc 2014 Oct 3 5 e001369

• Eugene P. Frenkel Outstanding Teacher of the Year
  UT Southwestern (2011)

• American College of Physician (1998)
• American Society of Hematology (2002)
• Hemophilia and Thrombosis Research Society (2009)
• International Society on Thrombosis and Haemostasis (2003)